UPDATE 2-Lilly breast cancer drug stumbles, but trial continues

Aug 10 (Reuters) - U.S. drugmaker Eli Lilly and Co

on Wednesday said it would continue a late-stage trial of its

experimental breast cancer drug in combination with a widely

used treatment even...

Read more